A new pyridazine series of GABAA alpha5 ligands.

Monique B van Niel,Kevin Wilson, Charles H Adkins,John R Atack,José L Castro, Dawn E Clarke, Stephen Fletcher,Ute Gerhard, Mark M Mackey,Sallie Malpas, Karen Maubach,Robert Newman, Desmond O'Connor, Gopalan V Pillai,Peter B Simpson,Steven R Thomas,Angus M MacLeod

Journal of medicinal chemistry（2005）

引用 7|浏览11

暂无评分

摘要

Screening of the Merck compound collection identified 6 as an unusually simple, low molecular weight hit with moderate affinity for GABAA receptors. The structural novelty of 6, compared to our advanced series of GABAA alpha5 inverse agonists, made it an attractive molecule for further exploration. This paper will describe the evolution of 6 into a new series of ligands with nanomolar affinity and functional selectivity for GABAA alpha5 receptor subtypes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要